
TriMas Corporation (NASDAQ:TRS - Free Report) - KeyCorp issued their Q4 2025 earnings per share estimates for shares of TriMas in a research note issued to investors on Tuesday, August 12th. KeyCorp analyst K. Newman expects that the industrial products company will earn $0.44 per share for the quarter. KeyCorp has a "Overweight" rating and a $45.00 price target on the stock. The consensus estimate for TriMas' current full-year earnings is $1.69 per share. KeyCorp also issued estimates for TriMas' Q1 2026 earnings at $0.58 EPS, Q4 2026 earnings at $0.55 EPS and FY2026 earnings at $2.53 EPS.
TriMas (NASDAQ:TRS - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The industrial products company reported $0.61 earnings per share for the quarter, topping analysts' consensus estimates of $0.50 by $0.11. The company had revenue of $274.76 million during the quarter, compared to analysts' expectations of $251.18 million. TriMas had a return on equity of 11.49% and a net margin of 3.83%.TriMas's quarterly revenue was up 14.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.43 EPS. TriMas has set its FY 2025 guidance at 1.950-2.100 EPS.
A number of other research firms have also recently weighed in on TRS. BWS Financial reaffirmed a "buy" rating and issued a $45.00 price target (up previously from $40.00) on shares of TriMas in a report on Wednesday, July 30th. Wall Street Zen raised TriMas from a "hold" rating to a "buy" rating in a report on Sunday, June 1st. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has an average rating of "Buy" and an average price target of $45.00.
Check Out Our Latest Stock Analysis on TRS
TriMas Price Performance
NASDAQ TRS traded up $0.16 during trading hours on Friday, reaching $37.35. The company's stock had a trading volume of 665,486 shares, compared to its average volume of 426,818. The firm has a market capitalization of $1.52 billion, a price-to-earnings ratio of 41.04 and a beta of 0.66. TriMas has a 1-year low of $19.33 and a 1-year high of $37.49. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.59 and a quick ratio of 1.44. The company's 50-day moving average is $31.48 and its two-hundred day moving average is $26.31.
Hedge Funds Weigh In On TriMas
A number of institutional investors and hedge funds have recently added to or reduced their stakes in TRS. Wells Fargo & Company MN boosted its stake in TriMas by 21.1% during the fourth quarter. Wells Fargo & Company MN now owns 37,729 shares of the industrial products company's stock worth $928,000 after buying an additional 6,573 shares during the last quarter. Raymond James Financial Inc. acquired a new position in TriMas during the fourth quarter worth $6,698,000. Sterling Capital Management LLC boosted its stake in TriMas by 815.5% during the fourth quarter. Sterling Capital Management LLC now owns 1,300 shares of the industrial products company's stock worth $32,000 after buying an additional 1,158 shares during the last quarter. Barclays PLC boosted its stake in TriMas by 51.4% during the fourth quarter. Barclays PLC now owns 104,163 shares of the industrial products company's stock worth $2,560,000 after buying an additional 35,371 shares during the last quarter. Finally, Advisory Research Inc. boosted its stake in TriMas by 41.2% during the fourth quarter. Advisory Research Inc. now owns 754,089 shares of the industrial products company's stock worth $18,543,000 after buying an additional 220,000 shares during the last quarter. Institutional investors and hedge funds own 99.42% of the company's stock.
Insider Activity at TriMas
In related news, Director Shawn Sedaghat acquired 72,937 shares of the stock in a transaction on Thursday, May 22nd. The shares were bought at an average price of $26.16 per share, with a total value of $1,908,031.92. Following the completion of the purchase, the director owned 1,883,758 shares of the company's stock, valued at approximately $49,279,109.28. This represents a 4.03% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Adrianne Shapira acquired 4,000 shares of the stock in a transaction on Thursday, June 5th. The shares were bought at an average cost of $25.82 per share, for a total transaction of $103,280.00. Following the purchase, the director directly owned 8,476 shares of the company's stock, valued at $218,850.32. The trade was a 89.37% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 78,203 shares of company stock valued at $2,045,220. Insiders own 14.20% of the company's stock.
TriMas Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, August 12th. Stockholders of record on Tuesday, August 5th were given a $0.04 dividend. The ex-dividend date was Tuesday, August 5th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.4%. TriMas's dividend payout ratio is 17.58%.
TriMas Company Profile
(
Get Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Stories

Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report